Skip to main content
Tech.euFundingExplorerBeta

IOmx Therapeutics

iOmx Therapeutics focuses on the development of first-in-class cancer therapeutics.

Munich, GermanyFounded 2016iomx.com ↗
Healthtech
← All companies
Total raised
€105M
€105,000,000
Funding rounds
2
Investors
7
distinct backers
Active since
2016-08
latest 2021-10

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood20
base rate 48% for Series B
  • ▼ Dormant (no round in 3+ cohort gaps)
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood20
base rate 12% (2+ rounds)
  • ▲ €100M+ raised
  • ▲ 10y since founding

Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

2 rounds
DateStageAmountInvestors
2021-10-05Series B€65MAthos Service,M Ventures,MIG Capital,Sofinnova Partners,Wellington PartnersView deal →
2016-09-01Series A€40MMerck Ventures,MPM Capital,Sofinnova Partners,Wellington PartnersView deal →

Investors

7
Athos ServiceM VenturesMerck VenturesMIG CapitalMPM CapitalSofinnova PartnersWellington Partners

Related news

Similar companies

same sector or country